Physician

Stephen Michael Matlock

According to 2025 Medicare claims, Stephen Matlock (NPI: 1811494727) practices dermatology in the Joplin, MO-KS market, with the plurality of this provider's patient population coming from Jasper, MO. This provider's primary affiliated billing organization is DERMATOLOGY AND SKIN CANCER SPECIALISTS, LLC. (NPI: 1366632697; TIN: 861072868) and primary practice location at 64804-2525.

Matlock's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 604 traditional Medicare patients, billed 3,961 HCPCS/CPT codes, and received $539,098 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,103 prescription claims across 570 beneficiaries totaling $95,871 in drug costs, led by Minocycline Hcl (Minocycline Hcl). Open Payments data shows 43 records totaling $799. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,165 and ending at $95,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$270K$539K2022 Medicare payment: $12,538 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $386,353 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $539,098 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202253194$12,538
20234842,650$386,353
20246043,961$539,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$94K$188K2018 Drug cost: $12,165 (USD; Tot_Drug_Cst)2019 Drug cost: $32,827 (USD; Tot_Drug_Cst)2020 Drug cost: $22,727 (USD; Tot_Drug_Cst)2021 Drug cost: $187,955 (USD; Tot_Drug_Cst)2022 Drug cost: $44,945 (USD; Tot_Drug_Cst)2023 Drug cost: $37,945 (USD; Tot_Drug_Cst)2024 Drug cost: $95,871 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181438$12,165
2019108292$32,827
2020113329$22,727
2021113361$187,955
202260120$44,945
2023401748$37,945
20245701,103$95,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks329431$426
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more289409$59
11102Biopsy of related skin growth, first growth169246$58
17000Destruction of precancer skin growth, 1 growth206304$31
17003Destruction of precancer skin growth, 2-14 growths159998$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Minocycline HclMinocycline Hcl3434,745$4,653
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav1321,267$1,292
AcitretinAcitretin11328$1,244
Gentamicin SulfateGentamicin Sulfate30677$1,189
Clobetasol PropionateClobetasol Propionate34951$924

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$799ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Stephen Michael Matlock?

Tedicare shows public-source Medicare data for Stephen Michael Matlock (NPI 1811494727), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Michael Matlock have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen Michael Matlock?

Stephen Michael Matlock is linked to DERMATOLOGY AND SKIN CANCER SPECIALISTS, LLC. (billing NPI 1366632697) in the available physician profile data.

Does Stephen Michael Matlock have Open Payments data?

Stephen Michael Matlock has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.